Could paraprobiotics be a safer alternative to probiotics for managing cancer chemotherapy-induced gastrointestinal toxicities?

Clinical oncology has shown outstanding progress improving patient survival due to the incorporation of new drugs. However, treatment success may be reduced by the emergency of dose-limiting side effects, such as intestinal mucositis and diarrhea. Mucositis and diarrhea management is symptomatic, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobre, L.M.S., Fernandes, C., Florêncio, K.G.D., Alencar, N.M.N., Wong, D.V.T., Lima-Júnior, R.C.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843735/
https://www.ncbi.nlm.nih.gov/pubmed/36651453
http://dx.doi.org/10.1590/1414-431X2022e12522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843735/
https://www.ncbi.nlm.nih.gov/pubmed/36651453
http://dx.doi.org/10.1590/1414-431X2022e12522

Ejemplares similares